Reckitt launches $664 million buyback on 4.7% revenue growth

Reckitt Benckiser Group reported 4.7% like-for-like net revenue growth in the second quarter, driven by strength in emerging markets.

"The broad-based acceleration across regions, categories and our Mead Johnson Nutrition business reflects the strength of our portfolio," Chief Executive Officer Kris Licht said.

Core like-for-like net revenue growth reached 4.2% in the second quarter, accelerating from 2.7% in the first half. Adjusted operating margins for core Reckitt and Mead Johnson Nutrition came in at 23.6%, ahead of expectations, supported by the Fuel for Growth program that mitigated stranded costs after the Essential Home divestment. First-half adjusted operating profit fell 15% year over year to 1.45 billion pounds, while first-half like-for-like net revenue rose 2.6%.

The new buyback program, worth $664 million, signals management's confidence in the company's cash generation and future prospects. Reckitt reiterated its full-year outlook, with investors now watching for further margin expansion as the Fuel for Growth initiative continues to offset divestiture-related costs.

The Lysol, Mucinex and Durex maker saw volumes improve and price-mix remain supportive during the quarter, with all regions contributing to the acceleration. The company did not disclose a specific timeline for the buyback execution.

The results come as Reckitt navigates the aftermath of its Essential Home divestment, which created stranded costs that the Fuel for Growth program was designed to address. The program's performance in the first half exceeded internal targets, helping the company maintain margins above 23%.

For holders, the buyback and reaffirmed guidance suggest management sees the current earnings trajectory as sustainable. The next catalyst for the stock will be the third-quarter trading update, where investors will assess whether emerging-market momentum can offset any slowdown in developed regions.

This article is for informational purposes only and does not constitute investment advice.